|
|
positive regulation of camp biosynthetic process
|
GO:0030819 |
35 |
0.955
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
47 |
0.914
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
60 |
0.734
|
|
|
|
pyrimidine ribonucleoside metabolic process
|
GO:0046131 |
11 |
0.707
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
45 |
0.645
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
38 |
0.588
|
|
|
|
nucleoside diphosphate metabolic process
|
GO:0009132 |
16 |
0.523
|
Human |
|
|
regulation of camp metabolic process
|
GO:0030814 |
52 |
0.422
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
79 |
0.386
|
|
|
|
pyrimidine ribonucleoside biosynthetic process
|
GO:0046132 |
2 |
0.375
|
|
|
|
camp metabolic process
|
GO:0046058 |
61 |
0.296
|
|
|
|
pyrimidine nucleotide biosynthetic process
|
GO:0006221 |
2 |
0.276
|
|
|
|
pyrimidine nucleotide metabolic process
|
GO:0006220 |
6 |
0.269
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
38 |
0.268
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
82 |
0.246
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.221
|
Human |
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
49 |
0.199
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
38 |
0.199
|
|
|
|
pyrimidine containing compound biosynthetic process
|
GO:0072528 |
4 |
0.197
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
50 |
0.192
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
41 |
0.180
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
61 |
0.178
|
|
|
|
pyrimidine nucleoside triphosphate biosynthetic process
|
GO:0009148 |
1 |
0.168
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.164
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
81 |
0.164
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
63 |
0.154
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.138
|
|
|
|
pyrimidine ribonucleoside triphosphate metabolic process
|
GO:0009208 |
2 |
0.138
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.131
|
|
|
|
regulation of phagocytosis engulfment
|
GO:0060099 |
2 |
0.128
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
2 |
0.116
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
82 |
0.108
|
|
|
|
positive regulation of epidermis development
|
GO:0045684 |
11 |
0.108
|
Human |
|
|
ctp metabolic process
|
GO:0046036 |
1 |
0.106
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.104
|
Human |
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.100
|
|
|
|
nucleotide phosphorylation
|
GO:0046939 |
15 |
0.100
|
Human |
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
49 |
0.096
|
|
|
|
pyrimidine nucleoside metabolic process
|
GO:0006213 |
13 |
0.090
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.083
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
130 |
0.082
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.082
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.080
|
|
|
|
purine ribonucleoside biosynthetic process
|
GO:0046129 |
23 |
0.077
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.074
|
Human |
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
65 |
0.074
|
Human |
|
|
cellular response to fatty acid
|
GO:0071398 |
8 |
0.073
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.071
|
|
|
|
pyrimidine containing compound metabolic process
|
GO:0072527 |
19 |
0.068
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.066
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.066
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.066
|
Human |
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.064
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.063
|
Human |
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.062
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.061
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
50 |
0.061
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.059
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.059
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.057
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.056
|
Human |
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.056
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.055
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.055
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.051
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.050
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.049
|
Human |
|
|
positive regulation of epidermal cell differentiation
|
GO:0045606 |
8 |
0.049
|
Human |
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.049
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
19 |
0.048
|
Human |
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.047
|
|
|
|
lipid modification
|
GO:0030258 |
84 |
0.047
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.045
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.045
|
Human |
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.044
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.044
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.044
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
92 |
0.044
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.043
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.043
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.043
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.043
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.042
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.041
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.041
|
Human |
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.041
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.040
|
|
|
|
regulation of keratinocyte differentiation
|
GO:0045616 |
11 |
0.040
|
Human |
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.039
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.038
|
Human |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.038
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.037
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.036
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.036
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.036
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.035
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.035
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.035
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.034
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.034
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.034
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.034
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.033
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.033
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.033
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
71 |
0.032
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.032
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.032
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.032
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.032
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.032
|
|
|
|
regulation of apoptotic cell clearance
|
GO:2000425 |
5 |
0.032
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
36 |
0.031
|
Human |
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.030
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.030
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.030
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
107 |
0.030
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
64 |
0.030
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.029
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.028
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.028
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.028
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
65 |
0.027
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.027
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.027
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.027
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.026
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.026
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.026
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.026
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.025
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.025
|
|
|
|
nucleoside triphosphate biosynthetic process
|
GO:0009142 |
20 |
0.025
|
Human |
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.025
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.025
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
32 |
0.025
|
Human |
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.025
|
Human |
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.025
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.025
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.024
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.024
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.024
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.024
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
123 |
0.023
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
72 |
0.023
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.023
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.023
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.022
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.022
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.022
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.022
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.022
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.022
|
|
|
|
negative regulation of myeloid leukocyte differentiation
|
GO:0002762 |
16 |
0.022
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.022
|
|
|
|
response to fatty acid
|
GO:0070542 |
13 |
0.022
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.022
|
|
|
|
phosphatidylinositol metabolic process
|
GO:0046488 |
53 |
0.022
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
99 |
0.021
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.021
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.021
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
44 |
0.021
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.020
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.020
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.020
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.020
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.020
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.019
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.019
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.019
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.019
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.019
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.019
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.019
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.018
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.018
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.018
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.018
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.018
|
Human |
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.018
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
11 |
0.018
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.018
|
|
|
|
response to monosaccharide
|
GO:0034284 |
20 |
0.018
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.017
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.017
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.017
|
|
|
|
protein tetramerization
|
GO:0051262 |
47 |
0.017
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.017
|
|
|
|
response to uv
|
GO:0009411 |
73 |
0.017
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.017
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.017
|
|
|
|
negative regulation of catabolic process
|
GO:0009895 |
104 |
0.017
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.016
|
|
|
|
purine nucleoside biosynthetic process
|
GO:0042451 |
23 |
0.016
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.016
|
|
|
|
growth
|
GO:0040007 |
202 |
0.016
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.016
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.016
|
|
|
|
leukocyte migration
|
GO:0050900 |
107 |
0.016
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
84 |
0.016
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.016
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.016
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
31 |
0.016
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.016
|
|
|
|
negative regulation of response to external stimulus
|
GO:0032102 |
83 |
0.016
|
|
|
|
nucleoside biosynthetic process
|
GO:0009163 |
26 |
0.016
|
|
|
|
ribonucleoside biosynthetic process
|
GO:0042455 |
25 |
0.016
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.016
|
|
|
|
positive regulation of neurogenesis
|
GO:0050769 |
49 |
0.015
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.015
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.015
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
15 |
0.015
|
Human |
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.015
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.015
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.015
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
39 |
0.015
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.015
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.015
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.015
|
|
|
|
pyrimidine ribonucleotide metabolic process
|
GO:0009218 |
4 |
0.015
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
37 |
0.014
|
|
|
|
phagocytosis
|
GO:0006909 |
42 |
0.014
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.014
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
57 |
0.014
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.014
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.014
|
|
|
|
glycosyl compound biosynthetic process
|
GO:1901659 |
27 |
0.014
|
|
|
|
protein targeting to membrane
|
GO:0006612 |
42 |
0.014
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.014
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.014
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.014
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.014
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.014
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.014
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.014
|
|
|
|
response to acid chemical
|
GO:0001101 |
66 |
0.014
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.014
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.014
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.014
|
|
|
|
response to hexose
|
GO:0009746 |
20 |
0.014
|
|
|
|
response to carbohydrate
|
GO:0009743 |
21 |
0.014
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.014
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.014
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.014
|
|
|
|
purine ribonucleoside triphosphate biosynthetic process
|
GO:0009206 |
11 |
0.014
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
10 |
0.013
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.013
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.013
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.013
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.013
|
|
|
|
response to peptide hormone
|
GO:0043434 |
61 |
0.013
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.013
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.013
|
|
|
|
defense response to fungus
|
GO:0050832 |
4 |
0.013
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.013
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.013
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.013
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.013
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.013
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.013
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.013
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
2 |
0.013
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.013
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.013
|
|
|
|
phospholipid biosynthetic process
|
GO:0008654 |
44 |
0.013
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.012
|
|
|
|
negative regulation of synaptic transmission
|
GO:0050805 |
2 |
0.012
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.012
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
128 |
0.012
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
34 |
0.012
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.012
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.012
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.012
|
|
|
|
lipid oxidation
|
GO:0034440 |
33 |
0.012
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.012
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.012
|
|
|
|
negative regulation of protein binding
|
GO:0032091 |
35 |
0.012
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
70 |
0.012
|
|
|
|
nuclear division
|
GO:0000280 |
128 |
0.012
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.012
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.012
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.012
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.012
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.012
|
|
|
|
glucose homeostasis
|
GO:0042593 |
31 |
0.012
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.012
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.012
|
|
|
|
positive regulation of dna binding
|
GO:0043388 |
17 |
0.012
|
|
|
|
inflammatory response
|
GO:0006954 |
79 |
0.012
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.012
|
|
|
|
epidermal cell differentiation
|
GO:0009913 |
45 |
0.012
|
Human |
|
|
cellular response to glucose stimulus
|
GO:0071333 |
10 |
0.012
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.012
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
86 |
0.012
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.012
|
|
|
|
phosphatidylinositol biosynthetic process
|
GO:0006661 |
25 |
0.012
|
|
|
|
tonic smooth muscle contraction
|
GO:0014820 |
3 |
0.012
|
|
|
|
response to fungus
|
GO:0009620 |
4 |
0.012
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.012
|
|
|
|
bone mineralization
|
GO:0030282 |
34 |
0.012
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
24 |
0.011
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.011
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.011
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.011
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.011
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.011
|
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.011
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.011
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.011
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.011
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.011
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.011
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.011
|
|
|
|
cell chemotaxis
|
GO:0060326 |
112 |
0.011
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.011
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.011
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.011
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.011
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
46 |
0.011
|
|
|
|
regulation of mesenchymal stem cell proliferation
|
GO:1902460 |
1 |
0.011
|
|
|
|
positive regulation of acrosome reaction
|
GO:2000344 |
4 |
0.011
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.011
|
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
40 |
0.011
|
|
|
|
muscle system process
|
GO:0003012 |
81 |
0.011
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.011
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.010
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.010
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.010
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.010
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.010
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.010
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.010
|
|
|
|
regulation of immune effector process
|
GO:0002697 |
91 |
0.010
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.010
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.010
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.010
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.010
|
|